DUBLIN--(BUSINESS WIRE)--Jun. 4, 2014--
plc (NYSE: MNK), a leading global specialty pharmaceutical company, will
present at the Goldman Sachs Global Healthcare Conference in Rancho
Palos Verdes, CA on Wednesday, June 11. Mark Trudeau, President and
Chief Executive Officer of Mallinckrodt, will represent the company in a
session scheduled to begin at 10:00AM PDT.
A live audio webcast of the presentation can be accessed at
Mallinckrodt’s Investor Relations website: http://www.mallinckrodt.com/investor_relations
and a replay will be available for 14 days following the presentation.
Mallinckrodt is a global specialty pharmaceutical and medical imaging
business that develops, manufactures, markets and distributes specialty
pharmaceutical products and medical imaging agents. The company’s core
strengths include the acquisition and management of highly regulated raw
materials; deep regulatory expertise; and specialized chemistry,
formulation and manufacturing capabilities. The company’s Specialty
Pharmaceuticals segment includes branded and specialty generic drugs and
active pharmaceutical ingredients, and the Global Medical Imaging
segment includes contrast media and nuclear imaging agents. Mallinckrodt
has approximately 5,500 employees worldwide and a commercial presence in
approximately 65 countries. The company’s fiscal 2013 revenue totaled
$2.2 billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
John Moten, 314-654-6650
Vice President, Investor